Abstract
Although the shear-dependent and reversible phenomenon of red blood cell (RBC) aggregation has been studied for decades, its role as a determinant of in vivo blood flow in both health and disease has not yet been fully documented. In this brief review, we present compelling arguments, supported by literature evidence, that in vivo flow dynamics are more affected by RBC aggregation than by RBC adhesion to endothelial cells (ECs). A companion article (i.e., a "counter-point") published in this issue of the journal argues that in disease states, RBC-EC adhesion is the more important determinant.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
